• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    How Earnings Estimate Upgrades Will Impact Reinsurance Group Of America Stock

    Simply Wall St·10/23/2026 12:39:32
    Listen to the news
    • Reinsurance Group of America recently saw earnings estimates revised upward for the current and next fiscal years, which points to higher expected profitability from its life and health reinsurance operations.
    • During the same period, a contrast has emerged between stronger earnings expectations and slower net premium and book value growth, raising questions about how efficiently Reinsurance Group of America can convert new business into sustainable capital generation.
    • We will now explore how Reinsurance Group of America’s upgraded earnings expectations could reshape its investment narrative built around biometric reinsurance.
    Capture that same earnings momentum story across the sector by lining up Reinsurance Group of America against a curated list of 29 high quality undervalued stocks.

    Reinsurance Group of America Investment Narrative Recap

    Owning Reinsurance Group of America means believing its biometric focused reinsurance engine can keep turning global insurance demand into consistent earnings, even while book value growth looks softer. The short term swing factor is whether recent earnings momentum can be repeated through disciplined capital deployment into Asia Pacific, U.S. and Europe deals without stretching the balance sheet.

    The biggest operational risk right now is that slower pension risk transfer volumes in the U.S. and U.K. persist and drag on premiums, just as expectations around margin improvement and earnings growth rise. If those transactions do not recover, the story leans harder on digital underwriting programs, excess capital deployment and mortality experience to do the heavy lifting.

    The most relevant update around this earnings driven news is the roughly US$2.2b of excess capital and the plan to pay down about US$400 million of debt in September 2026. That combination matters because it gives Reinsurance Group of America room to keep writing in force and biometric heavy business while still funding dividends and other shareholder returns.

    For you, the link to catalysts is straightforward. If management keeps channeling that surplus into Asia Pacific growth, U.S. underwriting partnerships and selective Europe and U.K. longevity or pension risk transfer structures, earnings quality and diversification remain central to the thesis. If pension flows stay weak or complex liabilities absorb more capital than expected, that same capital stack could feel tighter than it looks today.

    Reinsurance Group of America Forecasts in Context

    Analyst models for Reinsurance Group of America sketch out a fairly tight set of assumptions. Revenue is expected to grow by 6.0% a year over the next three years, with profit margins projected to move from 5.8% today to 6.9% by 2029 as the biometric focused book scales. On those inputs, consensus sees earnings at about US$2.1b by 2029 compared with US$1.5b today, which implies an earnings increase of roughly US$600m over the period.

    Reinsurance Group of America's narrative projects US$30.9b revenue and US$2.1b earnings by 2029. This outlook implies 6.0% yearly revenue growth and an earnings increase of about US$600m from US$1.5b today.

    Those forecast numbers sit alongside a valuation framework that assumes the stock trades on a P/E of 10.3x in 2029, compared with 10.7x today and 10.6x for the broader U.S. insurance group. To bridge from current pricing to the analyst consensus target of US$277.33 per share, you would need to be comfortable that Reinsurance Group of America can deliver the US$30.9b revenue and US$2.1b earnings, apply a slightly lower multiple, and still retire roughly 0.63% of its share count each year.

    For investors benchmarking Reinsurance Group of America against the wider undervalued insurance and reinsurance peer set, these assumptions provide a useful grid. You can line up that 6.0% top line growth, the step up in margins and the implied P/E against other biometric heavy or life focused reinsurers to see where earnings momentum looks more conservatively underwritten and where expectations lean harder on multiple support.

    Uncover why Reinsurance Group of America's fair value is essentially in line with its current price.

    NYSE:RGA 1-Year Stock Price Chart
    NYSE:RGA 1-Year Stock Price Chart

    Exploring Other Perspectives

    One bullish twist on Reinsurance Group of America focuses on the US$44b value of in force business as the real earnings engine. Those optimistic analysts were already penciling in revenue of about US$33.0b and earnings of roughly US$2.3b by 2029. You now have fresh earnings momentum on the table, so it is worth exploring how both the upbeat and more cautious pre-news forecasts might shift from here.

    Explore 3 other Reinsurance Group of America fair value estimates, including one that suggests as much as 178% upside from the current price.

    Form Your Own Verdict

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so consider developing your own view.

    Looking for more investment ideas beyond Reinsurance Group of America?

    If the earnings story at Reinsurance Group of America has sharpened your focus, it can be useful to widen the lens and line it up against other listed businesses with different risk and return profiles. The Simply Wall St Screener gives you that broader menu in a structured way.